Recommended reading: Additional oxygen in the treatment of cystic fibrosis
PubMed Health. A service of the National Library of Medicine, National Institutes of Health.
A.D.A.M. Medical Encyclopedia [Internet]. Atlanta (GA): A.D.A.M.; 2013.
A.D.A.M. Medical Encyclopedia.
Cystic fibrosis is a disease passed down through families that causes thick, sticky mucus to build up in the lungs, digestive tract, and other areas of the body. It is one of the most common chronic lung diseases in children and young adults. It is a life-threatening disorder.

Causes, incidence, and risk factors
Cystic fibrosis (CF) is caused by a defective gene which causes the body to produce abnormally thick and sticky fluid, called mucus. This mucus builds up in the breathing passages of the lungs and in the pancreas, the organ that helps to break down and absorb food.
This collection of sticky mucus results in life-threatening lung infections and serious digestion problems. The disease may also affect the sweat glands and a man's reproductive system.
Millions of Americans carry the defective CF gene, but do not have any symptoms. That's because a person with CF must inherit two defective CF genes -- one from each parent. An estimated 1 in 29 Caucasian Americans have the CF gene. The disease is the most common, deadly, inherited disorder affecting Caucasians in the United States. It's more common among those of Northern or Central European descent.
Most children with CF are diagnosed by age 2. A small number, however, are not diagnosed until age 18 or older. These patients usually have a milder form of the disease.
Symptoms
Symptoms in newborns may include:
- Failure to gain weight normally during childhood
- No bowel movements in first 24 to 48 hours of life
- Salty-tasting skin
Symptoms related to bowel function may include:
- Belly pain from severe constipation
- Increased gas, bloating, or a belly that appears swollen (distended)
- Nausea and loss of appetite
- Stools that are pale or clay colored, foul smelling, have mucus, or that float
- Weight loss
Symptoms related to the lungs and sinuses may include:
- Coughing or increased mucus in the sinuses or lungs
- Nasal congestion caused by nasal polyps
- Recurrent episodes of pneumonia. Symptoms in someone with cystic fibrosis include:
- Fever
- Increased coughing
- Increased shortness of breath
- Loss of appetite
- More sputum
- Sinus pain or pressure caused by infection or polyps
Symptoms that may be noticed later in life:
- Infertility (in men)
- Repeated inflammation of the pancreas (pancreatitis)
- Respiratory symptoms
- Clubbed fingers

Signs and tests
A blood test is available to help detect CF. The test looks for variations in a gene known to cause the disease. Other tests use to diagnose CF include:
- Immunoreactive trypsinogen (IRT) test is a standard newborn screening test for CF. A high level of IRT suggests possible CF and requires further testing.
- Sweat chloride test is the standard diagnostic test for CF. A high salt level in the patient's sweat is a sign of the disease.
Other tests that identify problems that can be related to cystic fibrosis include:
- Measurement of pancreatic function
Treatment
An early diagnosis of CF and a comprehensive treatment plan can improve both survival and quality of life. Follow-up and monitoring are very important. If possible, patients should be cared for at cystic fibrosis specialty clinics, which can be found in many communities. When children reach adulthood, they should transfer to a cystic fibrosis specialty center for adults.
Treatment for lung problems includes:
- Antibiotics to prevent and treat lung and sinus infections. They may be taken by mouth, or given in the veins or by breathing treatments. People with cystic fibrosis may take antibiotics only when needed, or all the time. Doses are usually higher than normal.
- Inhaled medicines to help open the airways
- DNAse enzyme therapy to thin mucus and make it easier to cough up
- High concentration of salt solutions (hypertonic saline)
- Flu vaccine and pneumococcal polysaccharide vaccine (PPV) yearly (ask your health care provider)
- Lung transplant is an option in some cases
- Oxygen therapy may be needed as lung disease gets worse
Lung problems are also treated with aerobic exercise or other therapies to thin the mucous and make it easier to cough up out of the lungs. These include a Percussion Vest, manual chest percussion, A-capella, or TheraPEP device.
Treatment for bowel and nutritional problems may include:
- A special diet high in protein and calories for older children and adults
- Pancreatic enzymes to help absorb fats and protein
- Vitamin supplements, especially vitamins A, D, E, and K
- Your doctor can suggest other treatments if you have very hard stools
Care and monitoring at home should include:
- Avoiding smoke, dust, dirt, fumes, household chemicals, fireplace smoke, and mold or mildew.
- Drinking plenty of fluids. This is particularly true for infants, children, in hot weather, when there is diarrhea or loose stools, or during extra physical activity
- Exercising two or three times each week. Swimming, jogging, and cycling are good options.
- Clearing or bringing up mucus or secretions from the airways. This must be done one to fours times each day. Patients, families, and caregivers must learn about doing chest percussion and postural drainage to help keep the airways clear.

Support Groups
For additional information and resources, see: Cystic fibrosis support group
Expectations (prognosis)
Most children with cystic fibrosis are fairly healthy until they reach adulthood. They are able to participate in most activities and should be able to attend school. Many young adults with cystic fibrosis finish college or find employment.
Lung disease eventually worsens to the point where the person is disabled. Today, the average life span for people with CF who live to adulthood is approximately 37 years, a dramatic increase over the last three decades.
Death is usually caused by lung complications.
Complications
The most common complication is chronic respiratory infection.
- Infertility
- Liver disease or liver failure, pancreatitis, biliary cirrhosis
- Malnutrition
- Nasal polyps and sinusitis
- Pneumonia, recurrent
- Right-sided heart failure (cor pulmonale)
Calling your health care provider
Call your health care provider if an infant or child has symptoms of cystic fibrosis.
Call your health care provider if a person with cystic fibrosis develops new symptoms or if symptoms get worse, particularly severe breathing difficulty or coughing up blood.
Call your health care provider if you or your child experiences:
- Fever, increased coughing, changes in sputum or blood in sputum, loss of appetite, or other signs of pneumonia
- Increased weight loss
- More frequent bowel movements or stools that are foul-smelling or have more mucus
- Swollen belly or increased bloating
Prevention
There is no way to prevent cystic fibrosis. Screening those with a family history of the disease may detect the cystic fibrosis gene in 60 - 90% of carriers, depending on the test used.
References
- Flume PA, Mogayzel PJ Jr, Robinson KA, Rosenblatt RL, Quittell L, Marshall BC; Clinical Practice Guidelines for Pulmonary Therapies Committee; Cystic Fibrosis Foundation Pulmonary Therapies Committee. Cystic fibrosis pulmonary guidelines: pulmonary complications: hemoptysis and pneumothorax. Am J Respir Crit Care Med. 2010 Aug 1;182(3):298-306. [PubMed: 20675678]
- Farrell PM, Rosenstein BJ, White TB, et al. Guidelines for diagnosis of cystic fibrosis in newborns through older adults: Cystic fibrosis consensus report. Journal of Pediatrics. Aug 2008;153(2). [PMC free article: PMC2810958] [PubMed: 18639722]
- Stallings VA, Stark LF, Robinson KA, Feranchak AP, Quinton H. Evidence-based practice recommendations for nutrition-related management of children and adults with cystic fibrosis and pancreatic insufficiency: Results of a systematic review. Journal of the American Dietetic Association. May 2008;108(5). [PubMed: 18442507]
- Mogayzel PJ Jr, Flume PA. Update in cystic fibrosis 2009. Am J Respir Crit Care Med. 2010 Mar 15;181(6):539-44. [PubMed: 20208039]
- Borowitz D, Robinson KA, Rosenfeld M, et al. Cystic Fibrosis Foundation evidence-based guidelines for management of infants with cystic fibrosis. J Pediatr. 2009 Dec;155(6 Suppl):S73-93. [PubMed: 19914445]
Review Date: 5/16/2012.
Reviewed by: Neil K. Kaneshiro, MD, MHA, Clinical Assistant Professor of Pediatrics, University of Washington School of Medicine. Also reviewed by David Zieve, MD, MHA, Medical Director, A.D.A.M. Health Solutions, Ebix, Inc.
A.D.A.M., Inc. is accredited by URAC, also known as the American Accreditation HealthCare Commission (www.urac.org). URAC's accreditation program is an independent audit to verify that A.D.A.M. follows rigorous standards of quality and accountability. A.D.A.M. is among the first to achieve this important distinction for online health information and services. Learn more about A.D.A.M.'s editorial policy, editorial process and privacy policy. A.D.A.M. is also a founding member of Hi-Ethics and subscribes to the principles of the Health on the Net Foundation (www.hon.ch).
The information provided herein should not be used during any medical emergency or for the diagnosis or treatment of any medical condition. A licensed medical professional should be consulted for diagnosis and treatment of any and all medical conditions. Call 911 for all medical emergencies. Links to other sites are provided for information only — they do not constitute endorsementscof those other sites. © 1997–2011 A.D.A.M., Inc. Any duplication or distribution of the information contained herein is strictly prohibited.
Low‐molecular‐weight heparins for pain caused by obstruction of blood vessels in people with sickle cell disease
Sickle cell disease is one of the most common and severe genetic blood disorders in the world. As the result of a change in the haemoglobin gene, red blood cells are transformed into cells with a sickle shape. This sickling of red blood cells results in various complications, amongst which are vaso‐occlusive crises. In a vaso‐occlusive crisis, the sickled red blood cells tend to clot together and block blood flow,which leads to pain in the organ involved. The pain can be very debilitating and often requires administration of morphine. Medication that prevents blood from clotting in the vessels might represent a useful contribution to existing treatment options for vaso‐occlusive crises. Our search retrieved one study with a total of 253 participants, which compared tinzaparin (a low‐molecular‐weight heparin) versus placebo. Although data were limited, this study reported that tinzaparin reduces the number of days spent in hospital and reduces the pain (and the intensity of the pain) more rapidly. Two minor bleedings were reported in the tinzaparin group versus none in the placebo group. These data are not sufficient to support the conclusion that low‐molecular‐weight heparins are effective in the treatment of vaso‐occlusive crises in people with sickle cell disease. Additional studies with different types of low‐molecular‐weight heparin used in different forms of sickle cell disease, are necessary to confirm or dismiss the results of this single study. Vaso‐occlusive crises can be extremely debilitating and can have a significant impact on quality of life; therefore it is important to know whether low‐molecular‐weight heparins might serve as a useful treatment option (evidence of its effectiveness) with few side effects.
Making smart health choicesDevelop the skills to assess health advice and make better-informed decisions about your health and managing illness.
- Cystic fibrosisCystic fibrosisPubMed Health
Your browsing activity is empty.
Activity recording is turned off.
See more...